Notice: This company has been marked as potentially delisted and may not be actively trading. Akili (AKLI) News Today Add Compare Share Share Headlines Stock AnalysisEarningsHeadlinesInsider TradesOwnershipShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Akili Announces FDA Authorization of EndeavorOTC, the First FDA Clearance of a Digital Treatment for Adults with ADHD Through a Video GameJune 18, 2024 | businesswire.comAKILI INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akili, Inc. - AKLIJune 14, 2024 | prnewswire.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AKLI, CALT, SGE on Behalf of ShareholdersJune 7, 2024 | globenewswire.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AKLI, WIRE on Behalf of ShareholdersJune 5, 2024 | globenewswire.comSHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces An Investigation of the Merger and its Tender Offer, Expiring July 31, 2024, for Shares of Akili, Inc. – AKLIJune 5, 2024 | globenewswire.comSHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces An Investigation of the Merger and its Tender Offer, Expiring July 31, 2024, for Shares of Akili, Inc. - AKLIJune 4, 2024 | prnewswire.comAKLI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akili, Inc. Is Fair to ShareholdersJune 3, 2024 | businesswire.comAkili to be delisted after getting acquiredMay 29, 2024 | bizjournals.comShareholder Alert: Ademi LLP investigates whether Akili, Inc. has obtained a Fair Price for its Public ShareholdersMay 29, 2024 | prnewswire.comPureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health CompanyMay 29, 2024 | businesswire.comVirtual Therapeutics, Akili Interactive Enter Into Definitive Merger Agreement to Establish Leading Digital Health CompanyMay 29, 2024 | businesswire.comAkili reports Q1 results; suspends outlookMay 15, 2024 | msn.comAKLI Stock Earnings: Akili Beats EPS, Misses Revenue for Q1 2024May 14, 2024 | investorplace.comAkili Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 14, 2024 | businesswire.comTherapeutic video game maker Akili lays off workers for third time in 16 monthsMay 3, 2024 | bizjournals.comWhy Is Akili (AKLI) Stock Up 68% Today?April 30, 2024 | investorplace.comAkili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial ResultsApril 30, 2024 | businesswire.comTrading was temporarily halted for "AKLI" at 07:04 AM with a stated reason of "News pending."April 30, 2024 | marketbeat.comDigital medicine maker Akili slashed executive pay in 2023March 11, 2024 | bizjournals.comAkili Full Year 2023 Earnings: EPS Beats Expectations, Revenues LagMarch 3, 2024 | finance.yahoo.comAkili (AKLI) Gets a Buy from TD CowenMarch 1, 2024 | markets.businessinsider.comAkili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateFebruary 29, 2024 | businesswire.comPreview: Akili's EarningsFebruary 28, 2024 | benzinga.comAkili's ADHD digital therapy seeks Japan approvalFebruary 28, 2024 | investing.comCrude Oil Gains 1%; US New Home Sales Increase In JanuaryFebruary 27, 2024 | msn.comPureTech Founded Entity Akili Announces Positive Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx ® for Pediatric ADHD Patients in JapanFebruary 27, 2024 | businesswire.comWhy Is Akili (AKLI) Stock Up 110% Today?February 26, 2024 | investorplace.comWhy Is Prescription Digital Medicine-Focused Akili Stock Trading Over 100% On Monday?February 26, 2024 | msn.comAkili's ADHD device submitted for Japanese approval, stock rallies 130%February 26, 2024 | seekingalpha.comAkili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in JapanFebruary 26, 2024 | finance.yahoo.comAkili Announces Positive Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx® for Pediatric ADHD Patients in JapanFebruary 26, 2024 | businesswire.comAkili Announces Release Date for Fourth Quarter and Full Year 2023 Financial Results, Provides Investor Communications and Board and Corporate Governance UpdatesFebruary 21, 2024 | finance.yahoo.comAkili Announces Release Date for Fourth Quarter and Full Year 2023 Financial Results, Provides Investor Communications and Board and Corporate Governance UpdatesFebruary 21, 2024 | businesswire.comAkili, Inc. (AKLI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?January 15, 2024 | finance.yahoo.comAkli Tadjer: French writer meets students in school race rowJanuary 8, 2024 | bbc.comWhat to Know About EndeavorRX, the Video Game to Treat ADHDDecember 26, 2023 | cnet.comAkili, Inc. (AKLI) Upgraded to Buy: Here's What You Should KnowDecember 21, 2023 | finance.yahoo.comThe Petri Dish: ADHD-treating videogame cleared for teens, CRISPR exec resignsDecember 21, 2023 | bizjournals.comAkili Inc Ordinary SharesDecember 19, 2023 | morningstar.comEndeavorRxⓇ, World’s First and Only Prescription Video Game Treatment, Secures FDA Label Expansion for Pediatric ADHD Patients Aged 13-17December 18, 2023 | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: Urogen Pharma (URGN) and Akili (AKLI)November 15, 2023 | markets.businessinsider.comAkili Inc Ordinary Shares AKLINovember 14, 2023 | morningstar.comAkili, Inc. (NASDAQ:AKLI) Q3 2023 Earnings Call TranscriptNovember 13, 2023 | finance.yahoo.comAkili Reports Third Quarter 2023 Financial Results and Provides Business UpdateNovember 10, 2023 | finanznachrichten.deEmployees with ADHD Aren't Reaching Their Full Potential at Work, Akili Study FindsOctober 14, 2023 | tmcnet.comEmployees with ADHD Aren’t Reaching Their Full Potential at Work, Akili Study FindsOctober 12, 2023 | finance.yahoo.comAkili Announces Leadership TransitionOctober 6, 2023 | finance.yahoo.comAnalyst Affirms Buy Rating for Akili, Emphasizing Shift to OTC Strategy and Potential Strategic PartnershipsOctober 5, 2023 | markets.businessinsider.comBuy Rating on Akili’s Stock: Strategic Shift, Cash Management, and Anticipated FDA Clearances Bolster OptimismOctober 2, 2023 | markets.businessinsider.comAkili Releases EndeavorOTC(TM) on Android(TM) Devices, Expanding Treatment Access for Millions of Adults with ADHDSeptember 21, 2023 | stockhouse.com Get Akili News Delivered to You Automatically Sign up to receive the latest news and ratings for AKLI and its competitors with MarketBeat's FREE daily newsletter. Email Address This Bull Market Indicator called NVDA at $116 (Ad)Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run… All you have to do is follow this link here AKLI Media Mentions By Week AKLI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AKLI News Sentiment▼0.000.46▲Average Medical News Sentiment AKLI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AKLI Articles This Week▼01▲AKLI Articles Average Week Get Akili News Delivered to You Automatically Sign up to receive the latest news and ratings for AKLI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TriSalus Life Sciences News TELA Bio News Fractyl Health News FONAR News Edap Tms News LENSAR News Vivani Medical News Modular Medical News Monogram Orthopaedics News InspireMD News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AKLI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akili, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akili With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AKLI Stock Alerts